Penn Davis McFarland’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Penn Davis McFarland's PFE Position: Q3 2026 in Review
Penn Davis McFarland reduced its Pfizer (PFE) stake by 0.27% in Q3 2026, selling an estimated $12.2K and leaving 168,955 shares worth $4.82M. The position accounts for 0.41% of the portfolio, ranked #38.
Penn Davis McFarland first reported a position in PFE in Q3 2019 and has held it in 14 quarters since. 1,285 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Penn Davis McFarland held 168,955 shares of Pfizer worth $4.82M as of Q3 2026.
- Penn Davis McFarland sold 460 Pfizer shares in Q3 2026, an estimated $12.2K.
- Pfizer made up 0.41% of Penn Davis McFarland's portfolio in Q3 2026, its #38 holding.
- Penn Davis McFarland first reported a position in Pfizer in Q3 2019 and has held it in 14 quarters since.
- 1,285 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Penn Davis McFarland's 13F filing for Q3 2026, filed 23 Oct 2026.